1-5 of 5
Hollie J. Pegram
Close
Sort by
Journal Articles

Abstract Title Submitted by Hollie Pegram to the 2012 ASH Annual Meeting: Expansion and Modification of Umbilical Cord Blood T Cells with a Chimeric Antigen Receptor and IL-12

Hollie J. Pegram, PhD, Juliet Barker, MBBS, Sergio Giralt, MD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1907.
https://doi.org/10.1182/blood.V120.21.1907.1907
Published: 2012
Journal Articles

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

Hollie J. Pegram, James C. Lee, Erik G. Hayman, Gavin H. Imperato, Thomas F. Tedder, Michel Sadelain, Renier J. Brentjens
Journal: Blood
Blood (2012) 119 (18): 4133–4141.
https://doi.org/10.1182/blood-2011-12-400044
Published: 2012
Includes: Supplemental data
Journal Articles

Tumor Specific T Cells Modified to Secrete IL-12 Eradicate Systemic Tumors in the Absence of Prior Toxic Chemotherapy Conditioning Regimens

Hollie J. Pegram, PhD, James Lee, MD, Erik Hayman, BS, Gavin H Imperato, Thomas J. Tedder, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3120.
https://doi.org/10.1182/blood.V118.21.3120.3120
Published: 2011
Journal Articles

Adoptive Therapy with Human CD19 (hCD19)-Targeted T Cells Further Modified to Express IL-12 Overcome the Need for Prior Lymphodepletion to Eradicate Established hCD19 + Tumors and Induce B Cell Aplasias In Immune Competent hCD19 + Transgenic Mice

Erik Hayman, BS, James Lee, MD, Hollie J. Pegram, PhD, Renier Brentjens, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2097.
https://doi.org/10.1182/blood.V116.21.2097.2097
Published: 2010
Journal Articles

CD19 Targeted Cord Blood Derived T Cells for Cancer Immunotherapy.

Hollie J. Pegram, PhD, Vincent LaRussa, PhD, Renier Brentjens, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3767.
https://doi.org/10.1182/blood.V116.21.3767.3767
Published: 2010